The tumor-inhibiting effects of WA had previously been attributed to the inhibition of the kinases (IKK) that phosphorylate and inactivate IkB, the inhibitor of NF-kB, preventing the activation of transcription factor NF-kB [131,132]. This evidence concerns the gene NFKB1 and neoplasm.